Seeking Alpha

Abbott Laboratories' (ABT) AbbVie spin-off is worth more than Abbott ahead of the official split...

Abbott Laboratories' (ABT) AbbVie spin-off is worth more than Abbott ahead of the official split of the company in January. "When issued" trading in the two entities began yesterday in the secondary market, with the new Abbott valued at $47.9B and AbbVie $55.3B. The market cap of the combined Abbott is $103.27B.
Comments (5)
  • Does anyone know if ABT shareholders will receive one share of AbbVie for each share of ABT they own? Any idea on the split prices of each ABT and AbbVie? Thanks
    11 Dec 2012, 12:26 PM Reply Like
  • I believe I read that we'll get shares of both companies, roughly equal, but amounting to the same dollar value in total as the dollar value of the Abt shares held before the Jan 1 split.
    11 Dec 2012, 04:13 PM Reply Like
  • November 28, 2012

     

    Abbott Park, Illinois (NYSE: ABT) — Abbott announced today that its board of directors has approved the separation of its research-based pharmaceuticals business, which will be known as AbbVie Inc., and declared a special dividend distribution of all of the outstanding shares of AbbVie common stock.

     

    For every 1 share of Abbott common shares held, Abbott shareholders will receive 1 share of AbbVie common stock. No fractional shares of AbbVie will be issued. Shareholders will receive cash in lieu of fractional shares. The special dividend distribution is expected to be paid on Jan. 1, 2013, to Abbott shareholders of record as of the close of business on Dec. 12, 2012.
    12 Dec 2012, 01:08 AM Reply Like
  • Does that mean if I sell my shares of ABT before 1 January 2013 I will still get my shares of AbbVie on 1 January 2013 or do the AbbVie shares stay with ABT if sold before 1 Jan 2013?
    26 Dec 2012, 03:51 PM Reply Like
  • And what if you purchase shares after Dec12 2012. Does the stock dividend not apply?
    2 Jan 2013, 06:16 PM Reply Like
DJIA (DIA) S&P 500 (SPY)